International Partnership for Microbicides, Inc.   Report issue

Foundation Phase 1 Phase 2 Phase 3
Founded: Silver Spring MD United States (2002)

Organization Overview

First Clinical Trial
2004
NCT00700284
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

International Partnership for Microbicides, Inc. | International Partnership for Microbicides (IPM)

Active Ingredients

Drugs in Phase 3 Trials (1)

dapivirine (40 trials)

Drugs in Phase 2 Trials (2)

levonorgestrel (2 trials)

tenofovir (viread) (2 trials)

Drugs in Phase 1 Trials (6)

ds003 (1 trial)

hydroxyethyl starch (voluven) (1 trial)

maraviroc (selzentry) (3 trials)

miconazole (monistat) (1 trial)

norgestrel (Ovral) (1 trial)

urea (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acquired Immunodeficiency Syndrome (Phase 2)

HIV Infections (Phase 3)

Immunologic Deficiency Syndromes (Phase 2)

Infections (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 43
  • # of Trial APIs: 9